KDM1B and clear cell renal carcinoma: Moreover, a recent pilot study suggests that histone acetylation and lysine-specific histone demethylase 2 (LSD2) are both involved in the NLRP3 inflammasome activation in clear-cell renal-cell carcinoma [89].